Wunderlich Capital Managemnt Pfizer Inc Transaction History

Wunderlich Capital Managemnt

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$30.12 - $36.54 $1.29 Million - $1.56 Million	-42,758 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $21,867 - $31,243	-809 Reduced 1.86%	42,758 $1.4 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $6,123 - $6,948	-186 Reduced 0.43%	43,567 $1.71 Million
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $8,544 - $11,080	-263 Reduced 0.6%	43,753 $1.57 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $46,964 - $52,730	1,270 Added 2.97%	44,016 $1.91 Million
Q1 2019 May 16, 2019	BUY	$37.5 - $41.2 $29,475 - $32,383	786 Added 1.87%	42,746 $1.82 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $5,578 - $6,359	-145 Reduced 0.34%	41,960 $1.83 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $68,285 - $82,825	-1,981 Reduced 4.49%	42,105 $1.86 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $21,997 - $23,451	667 Added 1.54%	44,086 $1.6 Million
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $7,115 - $8,255	223 Added 0.52%	43,419 $1.54 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $45,832 - $48,629	1,378 Added 3.3%	43,196 $1.57 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $1.3 Million - $1.43 Million	41,818	41,818 $1.49 Million

3,256

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $152B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

Stay updated on Wunderlich Capital Managemnt with notifications on news.